Coming Up: Strategic Positioning & Value Creation in AI-First Biotech Join leaders from OWKIN, Insilico Medicine, Recursion, and Third Rock Ventures as they go beyond model-building to explore how AI-driven biotech ventures can craft defensible strategies, stand out in a crowded field, and create long-term value. 🧠 Expect real talk on what it takes to succeed at the intersection of biotech and AI—from market positioning to growth strategy. 📅 Wednesday, April 2, 2025 | 2PM PST / 5PM EST 🔗 Register here: https://lnkd.in/gvTHqxr9 Panelists: • Michelle Chen, PhD – Chief Business Officer (CBO), Insilico Medicine • Aaron Arvey, PhD – Former Head of Computational Discovery , Third Rock Ventures • Jean-Frederic Petit-Nivard– Chief BD Officer, Owkin • Fatme D., PhD – Associate Director of BD, Recursion 🎙 Moderated by Michael Retchin
Nucleate
Biotechnology Research
Nucleate empowers tomorrow's biotech leaders by educating today's academic trainees
About us
Nucleate is a free, trainee-led 501(c)(3) non-profit organization dedicated to empowering the next generation of biotech leaders. As a global organization, we democratize biotech education, spark new intellectual communities, and build bridges within and across ecosystems by providing open-access programming, events and resources.
- Website
-
http://www.nucleate.xyz
External link for Nucleate
- Industry
- Biotechnology Research
- Company size
- 51-200 employees
- Headquarters
- Boston
- Type
- Nonprofit
- Founded
- 2019
Locations
-
Primary
Boston, US
Employees at Nucleate
-
Lital Gilad-Shaoulian
Founder & CEO
-
Zoya Gluzman-Poltorak
-
🤖 🧠 Thibault GEOUI 🧬 💊
Science CDO - Head of AI/ML for Drug R&D 💡- Bridging Science 🧠, Data 📊, and Technology (AI) 🤖 to Help Life Sciences Companies Bring Better…
-
Iris Stone, PhD
Computational Neuroscientist @ Allen Institute | Biotech Development
Updates
-
Excited to see Nucleate alumni among the 2025 Termeer Fellows! 🎉 Congratulations to: • Luca Giani – Co-Founder & CEO, Ilios Therapeutics • Robert Kruse – Co-Founder & CEO, HydroGene Therapeutics • Demetri Maxim – Founder & CEO, Nephrogen • Tere Williams – Founder & CEO, DUB Therapeutics Incredible recognition for these founders who continue to push the boundaries of biotech innovation. Can’t wait to see what’s next!
Welcoming the 2025 Termeer Fellows! We are honored to introduce the Class of 2025 Termeer Fellows—a distinguished group of 17 visionary leaders, our largest class to date, who are shaping the future of healthcare innovation. These first-time CEOs and founders are driving breakthrough discoveries and tackling some of the most complex challenges in biotech and life sciences, all with a steadfast commitment to transforming patient care. Through the Termeer Fellowship, these innovators will gain access to values-driven leadership content, expert mentorship, access to executive coaches, and a global network of industry leaders, all dedicated to accelerating their impact on patients worldwide. Now in its eighth year, the Fellowship remains committed to empowering the next generation of biotech pioneers with the support, community, and resources they need to thrive. Join us in congratulating the 2025 Termeer Fellows! Learn more about their groundbreaking work and the impact they are making in healthcare. Read more at https://lnkd.in/eCPFSXpD. 2025 Termeer Fellows: Rachel Abbott, CEO, Pan Cancer T Catherine "Katy" Digovich, CEO and Co-Founder, Minutia Aisling Foley, CEO and Co-Founder, ExCulture Sophia Lugo, CEO and Chairman, Radar Therapeutics Robert Kruse, CEO and Co-Founder, HydroGene Therapeutics Luca Giani, CEO and Co-Founder, Ilios Therapeutics Lauren Gehman, CEO and Co-Founder, Merge Therapeutics Antonio Henriques, CEO and Co-Founder, Momentum Therapeutics Alex Hersham, Co-Founder, Nonsense Tx Noor Jailkhani, CEO and Co-Founder, Matrisome Bio Demetri Maxim, CEO and Founder, Nephrogen Sheena McGowan, PhD, CEO and Co-Founder, Scudo Biosciences Ana Maria Moreno, CEO and Founder, Navega Therapeutics Josh Peters, CEO and Co-Founder, Prox Biosciences Carolina Pola, CEO, STAb Therapeutics J Ross, Ph.D., CEO and Co-Founder, Alleo Labs Tere Williams, CEO and Co-Founder, DUB Therapeutics
-
-
In Michelle Hoffmann’s experience as a consultant at Leerink Swann, Back Bay Life Sciences and elsewhere she learned the critical importance of incorporating multiple perspectives for successful drug development and uses this learning as the Executive Director of the Chicago Biomedical consortium. She learned: ▫️Understanding clinical decision-making—from how physicians treat patients to the role of insurance companies—is essential for translating science into real-world impact. ▫️Successful biotech development requires diverse perspectives, including insights from scientists, surgeons, investment bankers, and pharmacologists. ▫️Drug development is a team sport—it’s about collaboration and learning from each other's unique viewpoints, not just individual genius. 🎧 Tune in to hear more about how cross-disciplinary teams are driving the future of biotech innovation! https://lnkd.in/gRGzyH3J Youtube: https://lnkd.in/gSrcGuG8 Spotify: https://lnkd.in/gxZqQ2tu Apple Podcast: https://lnkd.in/gtgmgYfE #Biotech #Podcast #MedicalInnovation #ClinicalResearch #DrugDevelopment #ChicagoBiomedical #Collaboration #BiotechInnovation
-
What makes a biotech startup successful in Latin America? Investor interest in LATAM biotech is rising, but funding and infrastructure remain challenges. Our newest Hidden Layers article finds that founding teams make the difference: • PhDs lead scientific development as CSOs/CTOs • MBAs drive strategy and operations as CEOs/COOs • Industry & consulting experience accelerate growth and scaling • Strong networks help overcome funding gaps As biotech companies grow, leadership priorities shift—from securing early funding to scaling and commercialization. Read more in Signal, written by Romina Horianski. 🔗https://lnkd.in/gBWASAfu #biotech #LATAM #startups #venturecapital #HiddenLayers
-
-
Join us for a groundbreaking conversation on aging clocks and omics! On April 7, 2025, we’re hosting an insightful virtual session featuring two leading experts in the field of aging and longevity: 🎙 Steve Horvath – Principal Investigator at Altos Labs 🎙 Alan Tomusiak – CEO and Founder of Permanence Bio 🕛 When: 1 PM Eastern 📍 Where: Virtual (link to register below) These experts will explore how aging clocks, omics technologies, and computational tools are transforming the understanding of aging at the molecular level. Learn how these tools are driving innovation in aging research and therapeutic development. This is a must-attend event for: ▫️Researchers and students passionate about aging biology. ▫️Investors exploring emerging opportunities in longevity biotech. ▫️Anyone eager to understand how computational tools are unlocking the secrets of aging/ 💡 Don’t miss out—register today: https://lnkd.in/g3JfUxRH 💡 Let’s shape the future of aging science together! #AgingClocks #Longevity #Omics #ComputationalBiology #Innovation #Biotechnology #VirtualEvent
-
-
🌟 Empowering Future Biotech Leaders | Dr. Michelle Hoffmann, CBC 🌟 ▫️CBC Entrepreneurial Fellows conduct extensive diligence on emerging technologies, gaining hands-on experience in evaluating and funding up to $250K with clear go/no-go experiments. ▫️They gain real-world operational experience by managing projects and externing with local companies. ▫️Dedicate to creating their companies in Illinois. 🎧 Listen to the full episode to learn more about how we’re shaping the future of innovation! https://lnkd.in/gRGzyH3J YouTube: https://lnkd.in/gSrcGuG8 Spotify: https://lnkd.in/gxZqQ2tu Apple Podcasts: https://lnkd.in/gtgmgYfE #Biotech #Innovation #CBC #Entrepreneurship #Technology #Startups #Podcast
-
Wrapping up the ✨Inside Business Development Seminar ✨series with a powerful session on market evaluation and competitive landscape analysis. Join Preziosi Consultancy - Claudia Preziosi (Founder, Preziosi Consultancy & Head of BD at HepaTX) and Soumil Mhaskar (BD Finance Lead, Genentech) as they share insights and strategies for effectively evaluating your competitive landscape — a crucial step in assessing market opportunities. Don't miss this final session filled with real-world experience and actionable advice! Register here: https://lu.ma/l48uuv0d
-
-
Celebrating Women’s History Month: Inspiring Voices in Life Sciences Throughout history, extraordinary women have shattered barriers and made invaluable contributions as leaders in the life sciences. Their stories remind us that anything is possible when we believe in our own potential. Through the Women Leading Life Sciences virtual series, we had the privilege of hearing from some of these inspiring figures and learning from their unique journeys. To empower the next generation, we’re excited to spotlight the insights of Jessica Ballinger , Lori Gowen Morton, and Michele Stone, Ph.D., PMP , PMP — who share a powerful common thread: the courage to adapt, a vision for seizing opportunities, and the resolve to turn challenges into growth. This Women’s History Month, let’s celebrate the phenomenal women paving the way in science and leadership—while encouraging future leaders to dream even bigger. If you’re looking to make a difference in life sciences, remember their words: embrace uncertainty, seek out new possibilities, and inspire those around you. Together, we’ll keep the momentum going! 👩🔬💪🙌 #WomenInLifeSciences #NextGeneration #WomensHistoryMonth #WomenInSTEM #LifeSciences #Mentorship
-
-
📝 A Call to Support Undergraduate Research 📝 Today's undergraduates find themselves confronting growing challenges in accessing research opportunities. With recent funding cuts and downsized undergraduate research programs, students are losing the very experiences that shape their careers and contributions to science. Without action, we risk sidelining our future innovators before they even begin. Nucleate Dojo is calling on universities, funding agencies, and industry leaders to commit to sustaining and expanding financial support for undergraduate researchers. Investing in these students ensures that those with the passion and potential to drive scientific discovery have the opportunity to do so, regardless of financial circumstances. By signing this letter, you champion a future where all aspiring scientists have access to the experiences that shape careers, fuel discovery, and strengthen our scientific community. 📜 Read the full letter: https://lnkd.in/gyw82Kqj 🖊 Add your name to the call for action: https://lnkd.in/gfsXeQtd If your organization is interested in supporting the future of scientific innovation and entrepreneurship through undergraduate research funding, please contact us at dojo@nucleate.org. The next generation of scientific breakthroughs is coming. Together, let’s ensure it has the support it needs.
-
🌟 Empowering Future Biotech Leaders | Dr. Michelle Hoffmann, CBC 🌟 In our latest podcast hosted by Sam Kessel MD, MBA , Dr. Michelle Hoffmann discusses her unique journey from molecular neuroscience PhD to biotech consultant, and how her experiences shaped her passion for developing future leaders in the biotech industry in Chicago. Dr. Hoffmann’s career path took her from academia to consulting, including a decade at Back Bay Life Science Advisors, where she used her scientific expertise to help biotech companies optimize their product strategies and secure funding and building the biotech ecosystem in Chicago via the CBC Key insights from the conversation: 🔬 Bridging Science and Strategy – Leveraging her deep scientific background, Dr. Hoffmann helps biotech companies refine their product strategies and access capital. 🤝 Building an Innovative Ecosystem in Chicago – Dr. Hoffmann emphasizes the power of building cross-functional teams to lead biotechs in Chicago 🌱 Supporting Future Biotech Entrepreneurs – Through the CBC Entrepreneurial Fellows Program, Dr. Hoffmann is shaping the next generation of leaders who can lead with diverse perspectives and innovative strategies. Listen to the full podcast for inspiration on how to navigate the intersection of science, business, and leadership in the biotech world! 🎧 https://lnkd.in/gRGzyH3J More ways to listen: youtube: https://lnkd.in/gSrcGuG8 spotify: https://lnkd.in/gxZqQ2tu apple podcast: https://lnkd.in/gtgmgYfE The Entrepreneurial fellows program opens today check out the link here: https://lnkd.in/dim-ibH #Chicago #Biotech #CBCFellows #Leadership #Innovation #Entrepreneurship #CareerJourney #Consulting #Diversity